191 related articles for article (PubMed ID: 26647896)
1. [Immune System in Patients with Head and Neck Carcinoma].
Partlová S; Bouček J; Kloudová K; Zábrodský M; Špíšek R; Fialová A
Klin Onkol; 2015; 28 Suppl 4():4S86-94. PubMed ID: 26647896
[TBL] [Abstract][Full Text] [Related]
2. The interplay between HPV and host immunity in head and neck squamous cell carcinoma.
Andersen AS; Koldjaer Sølling AS; Ovesen T; Rusan M
Int J Cancer; 2014 Jun; 134(12):2755-63. PubMed ID: 23913554
[TBL] [Abstract][Full Text] [Related]
3. Peritumoral cuffing by T-cell tumor-infiltrating lymphocytes distinguishes HPV-related oropharyngeal squamous cell carcinoma from oral cavity squamous cell carcinoma.
Poropatich K; Hernandez D; Fontanarosa J; Brown K; Woloschak G; Paintal A; Raparia K; Samant S
J Oral Pathol Med; 2017 Nov; 46(10):972-978. PubMed ID: 28632936
[TBL] [Abstract][Full Text] [Related]
4. PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer.
Badoual C; Hans S; Merillon N; Van Ryswick C; Ravel P; Benhamouda N; Levionnois E; Nizard M; Si-Mohamed A; Besnier N; Gey A; Rotem-Yehudar R; Pere H; Tran T; Guerin CL; Chauvat A; Dransart E; Alanio C; Albert S; Barry B; Sandoval F; Quintin-Colonna F; Bruneval P; Fridman WH; Lemoine FM; Oudard S; Johannes L; Olive D; Brasnu D; Tartour E
Cancer Res; 2013 Jan; 73(1):128-38. PubMed ID: 23135914
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.
Albers A; Abe K; Hunt J; Wang J; Lopez-Albaitero A; Schaefer C; Gooding W; Whiteside TL; Ferrone S; DeLeo A; Ferris RL
Cancer Res; 2005 Dec; 65(23):11146-55. PubMed ID: 16322265
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of T cell response in the tumor milieu of patients with HPV
Bastian T; Lang S; Kansy BA
HNO; 2020 Feb; 68(2):80-86. PubMed ID: 31915881
[TBL] [Abstract][Full Text] [Related]
7. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
8. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH
APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083
[TBL] [Abstract][Full Text] [Related]
9. HNSCC: Tumour Antigens and Their Targeting by Immunotherapy.
von Witzleben A; Wang C; Laban S; Savelyeva N; Ottensmeier CH
Cells; 2020 Sep; 9(9):. PubMed ID: 32942747
[TBL] [Abstract][Full Text] [Related]
10. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
[TBL] [Abstract][Full Text] [Related]
11. Management of human papillomavirus-positive and human papillomavirus-negative head and neck cancer.
Mehra R; Ang KK; Burtness B
Semin Radiat Oncol; 2012 Jul; 22(3):194-7. PubMed ID: 22687943
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck.
Ringström E; Peters E; Hasegawa M; Posner M; Liu M; Kelsey KT
Clin Cancer Res; 2002 Oct; 8(10):3187-92. PubMed ID: 12374687
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring.
Paz IB; Cook N; Odom-Maryon T; Xie Y; Wilczynski SP
Cancer; 1997 Feb; 79(3):595-604. PubMed ID: 9028373
[TBL] [Abstract][Full Text] [Related]
14. CD56-positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma.
Wagner S; Wittekindt C; Reuschenbach M; Hennig B; Thevarajah M; Würdemann N; Prigge ES; von Knebel Doeberitz M; Dreyer T; Gattenlöhner S; Klussmann JP
Int J Cancer; 2016 May; 138(9):2263-73. PubMed ID: 26662627
[TBL] [Abstract][Full Text] [Related]
15. The Double-Edged Sword-How Human Papillomaviruses Interact With Immunity in Head and Neck Cancer.
Wang HF; Wang SS; Tang YJ; Chen Y; Zheng M; Tang YL; Liang XH
Front Immunol; 2019; 10():653. PubMed ID: 31001266
[TBL] [Abstract][Full Text] [Related]
16. The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma.
Fung N; Faraji F; Kang H; Fakhry C
Cancer Metastasis Rev; 2017 Sep; 36(3):449-461. PubMed ID: 28812214
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma.
Ang KK; Sturgis EM
Semin Radiat Oncol; 2012 Apr; 22(2):128-42. PubMed ID: 22385920
[TBL] [Abstract][Full Text] [Related]
18. Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
Sirianni N; Ha PK; Oelke M; Califano J; Gooding W; Westra W; Whiteside TL; Koch WM; Schneck JP; DeLeo A; Ferris RL
Clin Cancer Res; 2004 Oct; 10(20):6929-37. PubMed ID: 15501971
[TBL] [Abstract][Full Text] [Related]
19. Statistical analysis of human papillomavirus in a subset of upper aerodigestive tract tumors.
Liu H; Li J; Diao M; Cai Z; Yang J; Zeng Y
J Med Virol; 2013 Oct; 85(10):1775-85. PubMed ID: 23861229
[TBL] [Abstract][Full Text] [Related]
20. HPV and the Immune System in Head and Neck Cancers: Therapeutic Considerations.
Grinnell M; Krishnan M; Ganti AK
Oncology (Williston Park); 2020 Apr; 34(4):. PubMed ID: 32293695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]